A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/155 (2006.01) A61K 31/27 (2006.01) A61K 45/06 (2006.01) A61P 11/00 (2006.01) A61P 11/12 (2006.01)
Patent
CA 2433451
The invention relates to the use of a LTB4 antagonist or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the treatment and/or prevention of diseases caused by increased expression of mucin genes and/or hyperplasia of goblet cells induced by toxins of products of pathogenic bacteria in the bronchial or gastrointestinal epithelium.
La présente invention concerne l'utilisation d'un antagoniste de LTB4 ou d'un sel pharmaceutiquement acceptable de ce dernier dans la préparation d'un médicament destiné au traitement et/ou à la prévention de maladies causées par une expression augmentée des gènes de mucine et/ou une hyperplasie des cellules caliciformes induite par les toxines des produits de bactéries pathogènes dans l'épithélium bronchique ou gastrointestinal.
Anderskewitz Ralf
Birke Franz
Jennewein Hans Michael
Jung Birgit
Meade Christopher John Montague
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Fetherstonhaugh & Co.
LandOfFree
Use of an ltb4 antagonist for the treatment and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of an ltb4 antagonist for the treatment and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an ltb4 antagonist for the treatment and/or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1374314